Zeltiq Aesthetics Company Profile (NASDAQ:ZLTQ)

About Zeltiq Aesthetics (NASDAQ:ZLTQ)

Zeltiq Aesthetics logoZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company's product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ZLTQ
  • CUSIP: 98933Q10
  • Web: www.coolsculpting.com/
Average Prices:
  • 50 Day Moving Avg: $56.05
  • 200 Day Moving Avg: $46.95
  • 52 Week Range: $23.58 - $56.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 75.31
  • P/E Growth: 0.00
  • Net Margins: 9.78%
  • Return on Equity: 31.74%
  • Return on Assets: 20.11%
  • Current Ratio: 2.01%
  • Quick Ratio: 1.57%
  • Average Volume: 1.74 million shs.
  • Beta: 1.01

Frequently Asked Questions for Zeltiq Aesthetics (NASDAQ:ZLTQ)

What is Zeltiq Aesthetics' stock symbol?

Zeltiq Aesthetics trades on the NASDAQ under the ticker symbol "ZLTQ."

How were Zeltiq Aesthetics' earnings last quarter?

Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) announced its quarterly earnings data on Monday, August, 8th. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.05) by $0.07. The business earned $89.50 million during the quarter, compared to the consensus estimate of $79.68 million. Zeltiq Aesthetics had a net margin of 9.78% and a return on equity of 31.74%. The business's revenue was up 38.9% compared to the same quarter last year. During the same period last year, the company earned $0.03 EPS. View Zeltiq Aesthetics' Earnings History.

Where is Zeltiq Aesthetics' stock going? Where will Zeltiq Aesthetics' stock price be in 2017?

10 brokers have issued twelve-month price objectives for Zeltiq Aesthetics' stock. Their predictions range from $52.00 to $58.00. On average, they anticipate Zeltiq Aesthetics' stock price to reach $55.63 in the next twelve months. View Analyst Ratings for Zeltiq Aesthetics.

What are analysts saying about Zeltiq Aesthetics stock?

Here are some recent quotes from research analysts about Zeltiq Aesthetics stock:

  • 1. According to Zacks Investment Research, "Zeltiq Aesthetics Inc. is a medical technology company engaged in designing, development and commercialization of non-invasive procedures for the reduction of unwanted fat tissue. The Company offers CoolSculpting System and other products to the dermatologists, plastic surgeons, and aesthetic specialists in North America and internationally. Zeltiq Aesthetics Inc. is based in Pleasanton, California. " (4/13/2017)
  • 2. Canaccord Genuity analysts commented, "Date and time of first dissemination: March 09, 2017, 08:47 ET Date and time of production: March 09, 2017, 08:47 ET Target Price / Valuation Methodology: Zeltiq Aesthetics – ZLTQ Our price target is based off of Allergan’s acquisition price of $56.50 per share. Risks to achieving Target Price / Valuation: Zeltiq Aesthetics – ZLTQ Results are susceptible to macroeconomic factors Zeltiq’s business is dependent on macroeconomic factors such as unemployment, consumer confidence, and the availability of credit. Negative pressures on any or all of these growth factors could impact the company’s performance. High level of competition within non-invasive fat reduction industry Zeltiq operates in a fast-growing segment of the aesthetic medicine industry where there are a number of players constantly developing new enhancements to technology." (3/10/2017)

Who are some of Zeltiq Aesthetics' key competitors?

Who are Zeltiq Aesthetics' key executives?

Zeltiq Aesthetics' management team includes the folowing people:

  • Mark J. Foley, President, Chief Executive Officer
  • Taylor C. Harris, Chief Financial Officer, Senior Vice President
  • Brent Hauser, President - North America
  • Todd E. Zavodnick, President - International
  • Sergio Garcia, Senior Vice President, General Counsel and Corporate Secretary
  • Mike Fitzgerald, Senior Vice President - Global Human Resources
  • Danika R. Harrison, Vice President - Global Marketing
  • Carl H. Lamm, Vice President of Operations
  • Brad Hauser, Vice President - Research and Development

Who owns Zeltiq Aesthetics stock?

Zeltiq Aesthetics' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Alpine Associates Management Inc. (0.00%). Company insiders that own Zeltiq Aesthetics stock include Andrew N Schiff, Bradley Hauser, Carl Lamm, Keith J Sullivan, Kevin C Oboyle, Leonard C Debenedictis, Mark J Foley, Mary Fisher and Sergio Garcia. View Institutional Ownership Trends for Zeltiq Aesthetics.

How do I buy Zeltiq Aesthetics stock?

Shares of Zeltiq Aesthetics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zeltiq Aesthetics' stock price today?

One share of Zeltiq Aesthetics stock can currently be purchased for approximately $56.48.

MarketBeat Community Rating for Zeltiq Aesthetics (NASDAQ ZLTQ)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  311 (Vote Outperform)
Underperform Votes:  172 (Vote Underperform)
Total Votes:  483
MarketBeat's community ratings are surveys of what our community members think about Zeltiq Aesthetics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Zeltiq Aesthetics (NASDAQ:ZLTQ) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 8 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $55.63 (1.51% downside)

Analysts' Ratings History for Zeltiq Aesthetics (NASDAQ:ZLTQ)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/24/2017AegisReiterated RatingHold$56.00LowView Rating Details
3/10/2017Canaccord GenuityReiterated RatingHold$56.50N/AView Rating Details
3/2/2017Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
2/14/2017Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
2/14/2017Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
2/13/2017Maxim GroupDowngradeBuy -> HoldN/AView Rating Details
2/13/2017Northland SecuritiesReiterated RatingPositiveN/AView Rating Details
2/13/2017Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
8/9/2016J P Morgan Chase & CoReiterated RatingHold$27.00 -> $35.00N/AView Rating Details
4/8/2016Goldman Sachs Group, Inc. (The)Boost Price Target$35.00 -> $37.00N/AView Rating Details
1/22/2016Griffin SecuritiesUpgradeNeutral -> BuyN/AView Rating Details
(Data available from 9/21/2015 forward)


Earnings History for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Earnings by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Earnings History by Quarter for Zeltiq Aesthetics (NASDAQ ZLTQ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016Q316$0.08$0.12$90.84 million$95.20 millionViewListenView Earnings Details
8/8/2016Q216($0.05)($0.12)$79.68 million$89.50 millionViewN/AView Earnings Details
5/10/2016Q116($0.25)($0.25)$61.80 million$64.50 millionViewListenView Earnings Details
2/29/2016Q415$0.12$0.99$77.17 million$78.20 millionViewListenView Earnings Details
10/27/2015Q315($0.05)$0.05$58.18 million$61.20 millionViewListenView Earnings Details
7/30/2015Q215($0.04)$0.03$57.57 million$64.40 millionViewListenView Earnings Details
5/5/2015Q115($0.12)($0.06)$48.20 million$51.60 millionViewN/AView Earnings Details
3/3/2015Q414$0.01$0.03$50.70 million$50.80 millionViewN/AView Earnings Details
10/28/2014Q314($0.08)$0.12$40.20 million$45.70 millionViewN/AView Earnings Details
7/29/2014Q214($0.13)$0.07$34.93 million$47.10 millionViewN/AView Earnings Details
4/29/2014Q114($0.15)($0.20)$27.54 million$31.00 millionViewN/AView Earnings Details
2/25/2014Q413($0.12)($0.15)$33.28 million$35.80 millionViewN/AView Earnings Details
10/30/2013Q313($0.19)($0.08)$21.30 million$29.50 millionViewN/AView Earnings Details
11/7/2012Q312($0.22)($0.15)$20.62 million$17.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Zeltiq Aesthetics (NASDAQ:ZLTQ)
2017 EPS Consensus Estimate: $0.27
2018 EPS Consensus Estimate: $0.76
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174($0.21)($0.09)($0.14)
Q2 20174($0.08)$0.07$0.01
Q3 20174$0.16$0.28$0.20
Q4 20174$0.10$0.30$0.20
Q1 20181($0.03)($0.03)($0.03)
Q2 20181$0.17$0.17$0.17
Q3 20181$0.30$0.30$0.30
Q4 20181$0.32$0.32$0.32
(Data provided by Zacks Investment Research)


Dividend History for Zeltiq Aesthetics (NASDAQ:ZLTQ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Insider Ownership Percentage: 15.60%
Insider Trades by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Institutional Ownership by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Insider Trades by Quarter for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/13/2017Mark J FoleyInsiderSell10,000$55.77$557,700.00View SEC Filing  
2/21/2017Bradley HauserSVPSell3,000$55.64$166,920.00View SEC Filing  
1/13/2017Mark J FoleyInsiderSell10,000$41.72$417,200.00View SEC Filing  
1/4/2017Keith J SullivanInsiderSell8,000$44.36$354,880.00View SEC Filing  
12/13/2016Mark J FoleyInsiderSell10,000$44.08$440,800.00View SEC Filing  
12/8/2016Carl LammVPSell21,600$45.00$972,000.00View SEC Filing  
12/5/2016Keith J SullivanInsiderSell8,000$43.78$350,240.00View SEC Filing  
11/14/2016Mark J FoleyInsiderSell10,000$39.54$395,400.00View SEC Filing  
11/4/2016Keith J SullivanInsiderSell8,000$33.01$264,080.00View SEC Filing  
10/17/2016Sergio GarciaVPSell20,000$39.08$781,600.00View SEC Filing  
10/13/2016Mark J FoleyInsiderSell10,000$40.55$405,500.00View SEC Filing  
10/4/2016Keith J SullivanInsiderSell8,000$38.84$310,720.00View SEC Filing  
9/15/2016Carl LammVPSell3,125$40.00$125,000.00View SEC Filing  
9/15/2016Kevin C OboyleDirectorSell7,500$40.08$300,600.00View SEC Filing  
9/13/2016Mark J FoleyInsiderSell10,000$37.69$376,900.00View SEC Filing  
9/12/2016Bradley HauserVPSell3,000$37.33$111,990.00View SEC Filing  
9/6/2016Keith J SullivanInsiderSell8,000$38.36$306,880.00View SEC Filing  
8/15/2016Mark J FoleyInsiderSell10,000$37.26$372,600.00View SEC Filing  
8/11/2016Andrew N SchiffDirectorSell500,000$36.39$18,195,000.00View SEC Filing  
8/9/2016Kevin C OboyleDirectorSell17,500$37.86$662,550.00View SEC Filing  
8/9/2016Mark J FoleyInsiderSell50,000$37.89$1,894,500.00View SEC Filing  
8/5/2016Mark J FoleyInsiderSell50,000$35.01$1,750,500.00View SEC Filing  
8/4/2016Keith J SullivanInsiderSell8,000$34.37$274,960.00View SEC Filing  
7/13/2016Mark J FoleyCEOSell10,000$31.21$312,100.00View SEC Filing  
7/11/2016Bradley HauserVPSell3,000$30.02$90,060.00View SEC Filing  
7/11/2016Keith J SullivanInsiderSell8,000$30.02$240,160.00View SEC Filing  
4/13/2016Mark J FoleyCEOSell13,640$29.39$400,879.60View SEC Filing  
4/13/2016Mary FisherDirectorSell1,863$30.00$55,890.00View SEC Filing  
4/13/2016Sergio GarciaVPSell5,000$30.00$150,000.00View SEC Filing  
3/22/2016Mark J FoleyCEOSell9,698$25.01$242,546.98View SEC Filing  
3/21/2016Mark J FoleyCEOSell17,574$25.03$439,877.22View SEC Filing  
1/13/2016Mark J. FoleyCEOSell13,636$26.39$359,854.04View SEC Filing  
12/14/2015Mark J. FoleyCEOSell13,636$28.03$382,217.08View SEC Filing  
12/8/2015Mary FisherDirectorSell30,000$30.13$903,900.00View SEC Filing  
12/4/2015Leonard C. DebenedictisinsiderSell2,708$30.76$83,298.08View SEC Filing  
11/23/2015Andrew N SchiffDirectorSell255,992$30.73$7,866,634.16View SEC Filing  
11/19/2015Andrew N SchiffDirectorSell244,008$30.77$7,508,126.16View SEC Filing  
11/17/2015Carl LammVPSell2,341$31.66$74,116.06View SEC Filing  
11/13/2015Mark J. FoleyCEOSell13,636$32.17$438,670.12View SEC Filing  
11/13/2015Sergio GarciaVPSell5,000$31.92$159,600.00View SEC Filing  
11/4/2015Keith J. SullivanSVPSell1,200$34.28$41,136.00View SEC Filing  
11/2/2015Leonard C. DebenedictisinsiderSell10,479$33.92$355,447.68View SEC Filing  
10/13/2015Mark J. FoleyCEOSell13,636$31.80$433,624.80View SEC Filing  
10/5/2015Keith J. SullivanSVPSell13,700$32.60$446,620.00View SEC Filing  
10/1/2015Leonard C. DebenedictisinsiderSell2,709$31.91$86,444.19View SEC Filing  
9/14/2015Mark J. FoleyCEOSell13,636$35.30$481,350.80View SEC Filing  
9/4/2015Keith J. SullivanSVPSell13,700$31.62$433,194.00View SEC Filing  
9/1/2015Leonard C. DebenedictisinsiderSell2,708$31.60$85,572.80View SEC Filing  
8/13/2015Mark J FoleyCEOSell13,636$35.02$477,532.72View SEC Filing  
7/24/2015Kevin C OboyleDirectorSell3,900$33.00$128,700.00View SEC Filing  
7/14/2015Keith J SullivanSVPSell12,500$30.06$375,750.00View SEC Filing  
7/14/2015Leonard C DebenedictisInsiderSell1,563$30.00$46,890.00View SEC Filing  
7/13/2015Mark J FoleyCEOSell13,636$28.95$394,762.20View SEC Filing  
7/1/2015Leonard C DebenedictisInsiderSell1,146$30.00$34,380.00View SEC Filing  
6/25/2015Keith J SullivanSVPSell1,200$32.00$38,400.00View SEC Filing  
6/17/2015Keith J SullivanSVPSell12,500$30.00$375,000.00View SEC Filing  
6/17/2015Leonard C DebenedictisInsiderSell2,708$30.00$81,240.00View SEC Filing  
6/17/2015Patrick F WilliamsCFOSell22,045$30.00$661,350.00View SEC Filing  
6/17/2015Sergio GarciaVPSell10,000$30.00$300,000.00View SEC Filing  
6/15/2015Mark J FoleyCEOSell13,636$27.85$379,762.60View SEC Filing  
4/1/2015Leonard C DebenedictisInsiderSell2,709$30.22$81,865.98View SEC Filing  
3/2/2015Leonard C DebenedictisInsiderSell4,269$33.47$142,883.43View SEC Filing  
2/23/2015Carl LammVPSell2,315$34.16$79,080.40View SEC Filing  
2/17/2015Mark J FoleyCEOSell7,123$34.30$244,318.90View SEC Filing  
2/6/2015Carl LammVPSell6,205$35.00$217,175.00View SEC Filing  
2/5/2015Keith J SullivanSVPSell1,258$34.00$42,772.00View SEC Filing  
2/2/2015Leonard C DebenedictisInsiderSell5,125$31.46$161,232.50View SEC Filing  
1/26/2015Mary FisherDirectorSell52,602$32.18$1,692,732.36View SEC Filing  
1/20/2015Mark J FoleyCEOSell36,400$30.35$1,104,740.00View SEC Filing  
1/15/2015Jean GeorgeDirectorSell17,483$29.26$511,552.58View SEC Filing  
1/14/2015Mark J FoleyCEOSell7,123$29.25$208,347.75View SEC Filing  
1/12/2015Mark J FoleyCEOSell36,500$30.16$1,100,840.00View SEC Filing  
1/9/2015Keith J SullivanSVPSell1,200$30.00$36,000.00View SEC Filing  
1/9/2015Leonard C DebenedictisInsiderSell3,400$30.00$102,000.00View SEC Filing  
1/9/2015Patrick F WilliamsCFOSell10,400$30.21$314,184.00View SEC Filing  
1/9/2015Sergio GarciaVPSell1,647$30.00$49,410.00View SEC Filing  
1/5/2015Keith J SullivanSVPSell1,008$26.20$26,409.60View SEC Filing  
1/5/2015Sergio GarciaVPSell1,500$26.20$39,300.00View SEC Filing  
1/2/2015Leonard C DebenedictisInsiderSell3,400$27.63$93,942.00View SEC Filing  
12/18/2014Keith J SullivanSVPSell1,050$30.00$31,500.00View SEC Filing  
12/18/2014Leonard C DebenedictisInsiderSell41,073$30.00$1,232,190.00View SEC Filing  
12/18/2014Patrick F WilliamsCFOSell2,100$30.00$63,000.00View SEC Filing  
12/18/2014Sergio GarciaVPSell2,040$30.00$61,200.00View SEC Filing  
12/15/2014Mark J FoleyCEOSell7,123$28.97$206,353.31View SEC Filing  
12/5/2014Keith J SullivanSVPSell1,008$26.81$27,024.48View SEC Filing  
12/1/2014Leonard C DebenedictisInsiderSell3,400$26.55$90,270.00View SEC Filing  
11/20/2014Patrick F WilliamsCFOSell11,000$28.45$312,950.00View SEC Filing  
11/19/2014Sergio GarciaVPSell1,500$27.95$41,925.00View SEC Filing  
11/14/2014Mark J FoleyCEOSell7,123$26.92$191,751.16View SEC Filing  
11/5/2014Keith J SullivanSVPSell1,008$26.59$26,802.72View SEC Filing  
11/3/2014Carl LammVPSell1,808$25.19$45,543.52View SEC Filing  
11/3/2014Jean GeorgeDirectorSell17,483$25.15$439,697.45View SEC Filing  
11/3/2014Leonard C DebenedictisInsiderSell6,443$25.14$161,977.02View SEC Filing  
10/29/2014Mark J FoleyCEOSell25,000$25.81$645,250.00View SEC Filing  
10/27/2014Leonard C DebenedictisInsiderSell3,400$24.00$81,600.00View SEC Filing  
10/14/2014Mark J FoleyCEOSell7,123$21.61$153,928.03View SEC Filing  
10/1/2014Carl LammVPSell1,807$22.30$40,296.10View SEC Filing  
9/15/2014Mark J FoleyCEOSell57,123$25.52$1,457,778.96View SEC Filing  
9/11/2014Kevin C OboyleDirectorSell5,000$25.50$127,500.00View SEC Filing  
9/11/2014Patrick F WilliamsCFOSell8,000$25.48$203,840.00View SEC Filing  
9/11/2014Sergio GarciaSVPSell3,250$25.00$81,250.00View SEC Filing  
9/10/2014Leonard C DebenedictisCTOSell17,100$24.00$410,400.00View SEC Filing  
9/2/2014Carl LammVPSell1,807$21.36$38,597.52View SEC Filing  
8/14/2014Mark J FoleyCEOSell7,123$19.57$139,397.11View SEC Filing  
8/1/2014Carl LammVPSell2,291$20.18$46,232.38View SEC Filing  
7/31/2014Jean GeorgeDirectorSell29,157$20.09$585,764.13View SEC Filing  
7/30/2014Carl LammVPSell4,580$20.23$92,653.40View SEC Filing  
7/30/2014Kevin C OboyleDirectorSell5,000$21.08$105,400.00View SEC Filing  
7/30/2014Leonard C DebenedictisCTOSell2,500$20.23$50,575.00View SEC Filing  
7/30/2014Mark J FoleyCEOSell21,269$21.50$457,283.50View SEC Filing  
7/30/2014Sergio GarciaSVPSell1,250$21.01$26,262.50View SEC Filing  
6/2/2014Patrick F WilliamsCFOSell1,000$17.17$17,170.00View SEC Filing  
5/1/2014Carl LammVPSell2,290$18.01$41,242.90View SEC Filing  
5/1/2014Leonard DebenedictisCTOSell2,500$18.01$45,025.00View SEC Filing  
4/16/2014Mark FoleyCEOSell7,123$18.05$128,570.15View SEC Filing  
4/10/2014Leonard DebenedictisCTOSell10,071$18.61$187,421.31View SEC Filing  
4/1/2014Carl LammVPSell2,290$19.83$45,410.70View SEC Filing  
4/1/2014Patrick WilliamsCFOSell5,000$20.26$101,300.00View SEC Filing  
3/4/2014Kevin OboyleDirectorSell15,000$19.31$289,650.00View SEC Filing  
1/21/2014Jean Georgemajor shareholderSell31,080$22.62$703,029.60View SEC Filing  
1/17/2014Carl LammVPSell11,740$23.39$274,598.60View SEC Filing  
11/18/2013Carl LammVPSell2,347$15.41$36,167.27View SEC Filing  
11/14/2013Andrew SchiffDirectorSell575,000$12.22$7,026,500.00View SEC Filing  
10/4/2013Carl LammVPSell1,624$9.00$14,616.00View SEC Filing  
6/17/2013Kristine N TatsutaniSVPSell18,540$5.80$107,532.00View SEC Filing  
5/21/2013Sergio GarciaVPSell7,688$5.00$38,440.00View SEC Filing  
4/29/2013Keith J SullivanSVPBuy15,000$4.67$70,050.00View SEC Filing  
4/23/2013Kristine N TatsutaniSVPSell18,540$5.80$107,532.00View SEC Filing  
8/7/2012Bryan E RobertsDirectorBuy685,000$5.00$3,425,000.00View SEC Filing  
8/6/2012Bryan E RobertsDirectorBuy60,000$4.72$283,200.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Zeltiq Aesthetics (NASDAQ:ZLTQ)
Latest Headlines for Zeltiq Aesthetics (NASDAQ:ZLTQ)
businesswire.com logoRevance Appoints Mark Foley to its Board of Directors - Business Wire (press release)
www.businesswire.com - September 6 at 8:23 PM
americanbankingnews.com logoCritical Comparison: Illumina (ILMN) vs. Zeltiq Aesthetics (ZLTQ)
www.americanbankingnews.com - September 5 at 6:02 PM
nasdaq.com logoBotox-maker Allergan quarterly revenue rises 9 pct - Nasdaq
www.nasdaq.com - August 4 at 10:17 AM
reuters.com logoBotox-maker Allergan quarterly revenue rises 9 percent - Reuters
www.reuters.com - August 3 at 9:13 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (NASDAQ:ZLTQ) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - July 3 at 9:56 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - June 6 at 9:26 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Short Interest Update
www.americanbankingnews.com - May 13 at 7:08 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - May 12 at 9:53 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - May 6 at 1:01 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - May 6 at 12:42 AM
americanbankingnews.com logoZeltiq Aesthetics (ZLTQ) Receiving Somewhat Positive Media Coverage, AlphaOne Reports
www.americanbankingnews.com - May 2 at 10:36 AM
americanbankingnews.com logoSomewhat Favorable News Coverage Somewhat Likely to Affect Zeltiq Aesthetics (ZLTQ) Stock Price
www.americanbankingnews.com - April 29 at 9:16 AM
finance.yahoo.com logoNuVasive (NUVA) Beats on Q1 Earnings, Retains 2017 View
finance.yahoo.com - April 26 at 5:27 PM
finance.yahoo.com logoEdwards Lifesciences (EW) Tops Q1 Earnings, Updates '17 View
finance.yahoo.com - April 26 at 5:27 PM
finance.yahoo.com logoIllumina (ILMN) Posts In-line Earnings in Q1, Margins Down
finance.yahoo.com - April 26 at 5:27 PM
americanbankingnews.com logoZeltiq Aesthetics (ZLTQ) Earns Media Sentiment Rating of 0.01
www.americanbankingnews.com - April 26 at 8:13 AM
americanbankingnews.com logoZeltiq Aesthetics' (ZLTQ) "Hold" Rating Reiterated at Aegis
www.americanbankingnews.com - April 24 at 2:08 PM
americanbankingnews.com logoZeltiq Aesthetics (ZLTQ) Getting Somewhat Favorable News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 23 at 11:49 AM
americanbankingnews.com logoSomewhat Favorable Media Coverage Very Likely to Affect Zeltiq Aesthetics (ZLTQ) Stock Price
www.americanbankingnews.com - April 20 at 9:17 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - April 17 at 11:07 AM
americanbankingnews.com logoSomewhat Favorable Press Coverage Somewhat Unlikely to Effect Zeltiq Aesthetics (ZLTQ) Stock Price
www.americanbankingnews.com - April 17 at 8:18 AM
americanbankingnews.com logo Brokerages Expect Zeltiq Aesthetics Inc (ZLTQ) Will Announce Quarterly Sales of $80.92 Million
www.americanbankingnews.com - April 16 at 8:06 AM
americanbankingnews.com logo Analysts Anticipate Zeltiq Aesthetics Inc (ZLTQ) to Post -$0.17 EPS
www.americanbankingnews.com - April 14 at 8:25 PM
americanbankingnews.com logoSomewhat Critical Media Coverage Extremely Likely to Effect Zeltiq Aesthetics (ZLTQ) Stock Price
www.americanbankingnews.com - April 14 at 8:44 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - April 13 at 11:17 AM
zacks.com logoAlign (ALGN) Upgraded to Buy on Invisalign System Prospects
www.zacks.com - April 13 at 8:55 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 8 at 8:00 AM
nasdaq.com logoPre-Market Most Active for Apr 6, 2017 : BSBR, MT, MBLY, ZLTQ, BAC, QQQ, XIV, JAZZ, FTR, CHK, SKM, SGYP - Nasdaq
www.nasdaq.com - April 7 at 1:43 PM
americanbankingnews.com logoShort Interest in Zeltiq Aesthetics Inc (ZLTQ) Rises By 17.4%
www.americanbankingnews.com - April 4 at 1:34 PM
feeds.benzinga.com logoSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against ZELTIQ Aesthetics, Inc.
feeds.benzinga.com - April 4 at 12:26 PM
finance.yahoo.com logoNuVasive (NUVA) Gets FDA 510(k) Clearance for CoRoent System
finance.yahoo.com - March 30 at 3:40 PM
finance.yahoo.com logoGenomic Health's GPS Predicts Metastatic Prostate Cancer
finance.yahoo.com - March 30 at 3:40 PM
zacks.com logoQIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics
www.zacks.com - March 30 at 8:35 AM
americanbankingnews.com logoZacks Investment Research Upgrades Zeltiq Aesthetics Inc (ZLTQ) to Buy
www.americanbankingnews.com - March 29 at 10:20 AM
prnewswire.com logoHow These Medical Equipment Stocks are Faring? -- Zimmer Biomet, ZELTIQ ...
www.prnewswire.com - March 29 at 8:15 AM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 21 at 1:39 PM
biz.yahoo.com logoZELTIQ AESTHETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
biz.yahoo.com - March 16 at 8:52 AM
feeds.benzinga.com logoZELTIQ AESTHETICS MERGER ALERT – Andrews & Springer LLC Is Investigating ZELTIQ Aesthetics, Inc. For Potential Breaches of Fiduciary Duty
feeds.benzinga.com - March 15 at 8:06 PM
finance.yahoo.com logoZELTIQ AESTHETICS (ZLTQ) SHAREHOLDER ALERT – Andrews & Springer LLC is Investigating ZELTIQ Aesthetics, Inc. for Potential Breaches of Fiduciary Duty
finance.yahoo.com - March 13 at 8:32 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders
finance.yahoo.com - March 13 at 8:32 PM
americanbankingnews.com logoZeltiq Aesthetics Inc (ZLTQ) Sees Large Decrease in Short Interest
www.americanbankingnews.com - March 11 at 7:33 AM
prnewswire.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ZELTIQ Aesthetics, Inc. - ZLTQ - PR Newswire (press release)
www.prnewswire.com - March 10 at 7:04 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ZELTIQ Aesthetics, Inc. - ZLTQ
finance.yahoo.com - March 10 at 7:04 AM
finance.yahoo.com logoZELTIQ AESTHETICS INC Financials
finance.yahoo.com - March 8 at 3:48 AM
streetinsider.com logoZELTIQ Aesthetics (ZLTQ) to Showcase CoolAdvantage Petite applicator at AAD Meeting - StreetInsider.com
www.streetinsider.com - March 5 at 8:00 AM
finance.yahoo.com logoZELTIQ® Showcases CoolAdvantage Petite™ Applicator for the CoolSculpting® System at American Academy of Dermatology Annual Meeting
finance.yahoo.com - March 4 at 5:40 AM
us.rd.yahoo.com logoZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results
us.rd.yahoo.com - March 2 at 6:40 AM
biz.yahoo.com logoZELTIQ AESTHETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
us.rd.yahoo.com - March 2 at 6:40 AM
wsj.com logo[$$] Gormley's Take: Body Beautification Is Sexy Business
www.wsj.com - February 22 at 10:50 AM
thestreet.com logoMedtronic Earnings Rebound in Third Quarter, Shares Climb
www.thestreet.com - February 21 at 4:21 PM



Zeltiq Aesthetics (ZLTQ) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by MarketBeat.com Staff